Here are six notes:
1. The market will grow at a compound annual growth rate of 3.6 percent.
2. An increasing aging population and growing prevalence of osteoarthritis and rheumatoid arthritis will spur market growth.
3. The United States will dominate the market, growing at a 3.7 percent CAGR, up from $18.6 million in 2016 to $24 million in 2023.
4. The majority of orthopedic companies focus on hip, knee and shoulder implant development, so the elbow market accounts for a small chunk of the orthopedics market.
5. The elbow replacement implant average selling price will continue to drop because of competition and unfavorable reimbursements, but revenues from more procedures will likely even out this loss.
6. Memphis, Tenn.-based Wright Medical; Warsaw, Ind.-based Zimmer Biomet and Plainsboro, N.J.-based Integra LifeSciences lead the market.
More articles on orthopedics:
Orthopedic surgeon to know: Dr. Jaclyn Bailey of Twin Cities Orthopedics
Adena Bone & Joint Center welcomes Dr. Eric Storts — 4 details
Orthopedic surgeon leader to know: Dr. Richard Sweet of Louisville Orthopedic Clinic
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.